Two year persistent treatment effect in reducing nasal symptoms of cat allergy after 4 doses of Cat‐PAD, the first in a new class of synthetic peptide immuno‐regulatory epitopes
Gespeichert in:
| Veröffentlicht in: | Clinical and translational allergy 2013-07, Vol.3 (S2), p.O7-n/a |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | n/a |
|---|---|
| container_issue | S2 |
| container_start_page | O7 |
| container_title | Clinical and translational allergy |
| container_volume | 3 |
| creator | Hafner, Roderick Couroux, Peter Armstrong, Kristen Patel, Deepen Larche, Mark Haumann, Brett |
| description | |
| doi_str_mv | 10.1186/2045-7022-3-S2-O7 |
| format | Article |
| fullrecord | <record><control><sourceid>wiley_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3716539</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CLT2BF01005</sourcerecordid><originalsourceid>FETCH-LOGICAL-b3005-50e32553a77f280f5c11b5a9f5b99e5c004903b9505aa0a7570ff4351cf03bcb3</originalsourceid><addsrcrecordid>eNqFklFOGzEQhleolUDAAXibA7CtvY7ZLA-VaGgAKVIqkT5bs844GO2uV7bTaN96hF6mF-IkOAlCILWqH-zR_P4_jT2TZWecfeJ8fPG5YCOZl6wocpHfF_m8PMiOXnMf3sSH2WkIjywtOeZpP8r-LDYOBkIPPflgQ6QuQvSEsd1GZAzpCLYDT8u1tt0KOgzYQBjaPro2gDOgMQI2DfnVAGgieRjB0gXaiROMT79-f7-6Pof4QGCsDzseQkcb0A2G3bUwdEmOVqc6-miXBLZt151LXk-rdYPR-QGot9H1FE6yjwabQKcv53H2Y_ptMbnNZ_Obu8nVLK9FemIuGYlCSoFlaYoxM1JzXkusjKyriqRmbFQxUVeSSUSGpSyZMSMhuTYprWtxnH3Zc_t13dJSpy_x2Kje2xb9oBxa9V7p7INauZ9KlPxCiioBrveA2rp_AN4r2rVq2y61bZcS6r5Q8zJh-B6jvQvBk3klcKa2I_BXz-Xes7ENDf83qMlsUXydsjQXUjwDkO-86g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Two year persistent treatment effect in reducing nasal symptoms of cat allergy after 4 doses of Cat‐PAD, the first in a new class of synthetic peptide immuno‐regulatory epitopes</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Access via Wiley Online Library</source><source>Wiley Online Library (Open Access Collection)</source><source>PubMed Central</source><source>Springer Nature OA/Free Journals</source><creator>Hafner, Roderick ; Couroux, Peter ; Armstrong, Kristen ; Patel, Deepen ; Larche, Mark ; Haumann, Brett</creator><creatorcontrib>Hafner, Roderick ; Couroux, Peter ; Armstrong, Kristen ; Patel, Deepen ; Larche, Mark ; Haumann, Brett</creatorcontrib><identifier>ISSN: 2045-7022</identifier><identifier>EISSN: 2045-7022</identifier><identifier>DOI: 10.1186/2045-7022-3-S2-O7</identifier><language>eng</language><publisher>London: BioMed Central</publisher><subject>Oral Presentation ; Peptide ; Placebo ; Public Health ; Substantial Reduction ; Treatment Effect</subject><ispartof>Clinical and translational allergy, 2013-07, Vol.3 (S2), p.O7-n/a</ispartof><rights>2020 The Authors. Clinical and Translational Allergy published by John Wiley and Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology</rights><rights>Copyright © 2013 Hafner et al; licensee BioMed Central Ltd. 2013 Hafner et al; licensee BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b3005-50e32553a77f280f5c11b5a9f5b99e5c004903b9505aa0a7570ff4351cf03bcb3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716539/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716539/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,865,886,1418,11566,27928,27929,45578,45579,46056,46480,53795,53797</link.rule.ids></links><search><creatorcontrib>Hafner, Roderick</creatorcontrib><creatorcontrib>Couroux, Peter</creatorcontrib><creatorcontrib>Armstrong, Kristen</creatorcontrib><creatorcontrib>Patel, Deepen</creatorcontrib><creatorcontrib>Larche, Mark</creatorcontrib><creatorcontrib>Haumann, Brett</creatorcontrib><title>Two year persistent treatment effect in reducing nasal symptoms of cat allergy after 4 doses of Cat‐PAD, the first in a new class of synthetic peptide immuno‐regulatory epitopes</title><title>Clinical and translational allergy</title><subject>Oral Presentation</subject><subject>Peptide</subject><subject>Placebo</subject><subject>Public Health</subject><subject>Substantial Reduction</subject><subject>Treatment Effect</subject><issn>2045-7022</issn><issn>2045-7022</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><recordid>eNqFklFOGzEQhleolUDAAXibA7CtvY7ZLA-VaGgAKVIqkT5bs844GO2uV7bTaN96hF6mF-IkOAlCILWqH-zR_P4_jT2TZWecfeJ8fPG5YCOZl6wocpHfF_m8PMiOXnMf3sSH2WkIjywtOeZpP8r-LDYOBkIPPflgQ6QuQvSEsd1GZAzpCLYDT8u1tt0KOgzYQBjaPro2gDOgMQI2DfnVAGgieRjB0gXaiROMT79-f7-6Pof4QGCsDzseQkcb0A2G3bUwdEmOVqc6-miXBLZt151LXk-rdYPR-QGot9H1FE6yjwabQKcv53H2Y_ptMbnNZ_Obu8nVLK9FemIuGYlCSoFlaYoxM1JzXkusjKyriqRmbFQxUVeSSUSGpSyZMSMhuTYprWtxnH3Zc_t13dJSpy_x2Kje2xb9oBxa9V7p7INauZ9KlPxCiioBrveA2rp_AN4r2rVq2y61bZcS6r5Q8zJh-B6jvQvBk3klcKa2I_BXz-Xes7ENDf83qMlsUXydsjQXUjwDkO-86g</recordid><startdate>20130716</startdate><enddate>20130716</enddate><creator>Hafner, Roderick</creator><creator>Couroux, Peter</creator><creator>Armstrong, Kristen</creator><creator>Patel, Deepen</creator><creator>Larche, Mark</creator><creator>Haumann, Brett</creator><general>BioMed Central</general><general>BioMed Central Ltd</general><scope>24P</scope><scope>WIN</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20130716</creationdate><title>Two year persistent treatment effect in reducing nasal symptoms of cat allergy after 4 doses of Cat‐PAD, the first in a new class of synthetic peptide immuno‐regulatory epitopes</title><author>Hafner, Roderick ; Couroux, Peter ; Armstrong, Kristen ; Patel, Deepen ; Larche, Mark ; Haumann, Brett</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b3005-50e32553a77f280f5c11b5a9f5b99e5c004903b9505aa0a7570ff4351cf03bcb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Oral Presentation</topic><topic>Peptide</topic><topic>Placebo</topic><topic>Public Health</topic><topic>Substantial Reduction</topic><topic>Treatment Effect</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hafner, Roderick</creatorcontrib><creatorcontrib>Couroux, Peter</creatorcontrib><creatorcontrib>Armstrong, Kristen</creatorcontrib><creatorcontrib>Patel, Deepen</creatorcontrib><creatorcontrib>Larche, Mark</creatorcontrib><creatorcontrib>Haumann, Brett</creatorcontrib><collection>Wiley Online Library (Open Access Collection)</collection><collection>Wiley Online Library (Open Access Collection)</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical and translational allergy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hafner, Roderick</au><au>Couroux, Peter</au><au>Armstrong, Kristen</au><au>Patel, Deepen</au><au>Larche, Mark</au><au>Haumann, Brett</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Two year persistent treatment effect in reducing nasal symptoms of cat allergy after 4 doses of Cat‐PAD, the first in a new class of synthetic peptide immuno‐regulatory epitopes</atitle><jtitle>Clinical and translational allergy</jtitle><date>2013-07-16</date><risdate>2013</risdate><volume>3</volume><issue>S2</issue><spage>O7</spage><epage>n/a</epage><pages>O7-n/a</pages><issn>2045-7022</issn><eissn>2045-7022</eissn><cop>London</cop><pub>BioMed Central</pub><doi>10.1186/2045-7022-3-S2-O7</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2045-7022 |
| ispartof | Clinical and translational allergy, 2013-07, Vol.3 (S2), p.O7-n/a |
| issn | 2045-7022 2045-7022 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3716539 |
| source | DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Access via Wiley Online Library; Wiley Online Library (Open Access Collection); PubMed Central; Springer Nature OA/Free Journals |
| subjects | Oral Presentation Peptide Placebo Public Health Substantial Reduction Treatment Effect |
| title | Two year persistent treatment effect in reducing nasal symptoms of cat allergy after 4 doses of Cat‐PAD, the first in a new class of synthetic peptide immuno‐regulatory epitopes |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T17%3A34%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Two%20year%20persistent%20treatment%20effect%20in%20reducing%20nasal%20symptoms%20of%20cat%20allergy%20after%204%20doses%20of%20Cat%E2%80%90PAD,%20the%20first%20in%20a%20new%20class%20of%20synthetic%20peptide%20immuno%E2%80%90regulatory%20epitopes&rft.jtitle=Clinical%20and%20translational%20allergy&rft.au=Hafner,%20Roderick&rft.date=2013-07-16&rft.volume=3&rft.issue=S2&rft.spage=O7&rft.epage=n/a&rft.pages=O7-n/a&rft.issn=2045-7022&rft.eissn=2045-7022&rft_id=info:doi/10.1186/2045-7022-3-S2-O7&rft_dat=%3Cwiley_pubme%3ECLT2BF01005%3C/wiley_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |